Role of second-trimester ultrasound in screening for Down syndrome

Ultrasound in Obstetrics and Gynecology

Volumn 41, Issue 3, 2013, Pages 241-244

  Cuckle, H ^a   Maymon, R ^b  

^a NewYork Presbyterian Hospital   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; BLOOD; DOWN SYNDROME; ECHOGRAPHY; FEMALE; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; HUMAN; METHODOLOGY; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PRENATAL DIAGNOSIS; RISK; SECOND TRIMESTER PREGNANCY; TIME;

BIOLOGICAL MARKERS; DOWN SYNDROME; FEMALE; HUMANS; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; RISK; TIME FACTORS; ULTRASONOGRAPHY, PRENATAL;

EID: 84874702422     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.12397     Document Type: Note

References (29)

1. th edn), Milunsky A, Milunsky JM (eds). Johns Hopkins University Press: Baltimore, 2010; 771-818.
2. Cuckle HS, Wald NJ, Thompson SG,. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol 1987; 94: 387-402.
3. Cuckle H, Aitken D, Goodburn S, Senior B, Spencer K, Standing S,. Age-standardisation for monitoring performance in Down's syndrome screening programmes. Prenat Diagn 2004; 24: 851-856.
4. Agathokleous M, Chaveeva P, Poon LCY, Kosinski P, Nicolaides KH,. Meta-analysis of second-trimester markers for trisomy 21. Ultrasound Obstet Gynecol 2013; 41: 247-261.
5. Cuckle H., Down syndrome fetal loss rate in early pregnancy. Prenat Diagn 1999; 19: 1177-1179.
6. Aagaard-Tillery KM, Malone FD, Nyberg DA, Porter TF, Cuckle HS, Fuchs K, Sullivan L, Comstock CH, Sade GR, Eddleman K, Gross S, Dugoff L, Craigo S, Timor-Tritsch IE, Carr SR, Wolfe HM, Bianchi DW, D'Alton ME,. 2009. Role of second-trimester genetic sonography after Down syndrome screening. Obstet Gynecol 2009; 114: 1189-1196.
7. Cuckle H, Maymon R,. Down syndrome risk calculation for a twin fetus taking account of the nuchal translucency in the co-twin. Prenat Diagn 2010; 30: 827-833.
8. Wright D, Syngelaki A, Staboulidou I, Cruz Jde J, Nicolaides KH,. Screening for trisomies in dichorionic twins by measurement of fetal nuchal translucency thickness according to the mixture model. Prenat Diagn 2011; 31: 16-21.
9. Cleary-Goldman J, Rebarber A, Krantz D, Hallahan T, Saltzman D,. First-trimester screening with nasal bone in twins. Am J Obstet Gynecol 2008; 199: 283.e1-3.
10. Maiz N, Staboulidou I, Leal AM, Minekawa R, Nicolaides KH,. Ductus venosus Doppler at 11 to 13 weeks of gestation in the prediction of outcome in twin pregnancies. Obstet Gynecol 2009; 113: 860-865.
11. NHS Fetal Anomaly Screening Programme. Normal variant screening in pregnancy. Programme Statement 12/09/02. 2009. http://fetalanomaly.screening. nhs.uk/programmestatements#fileid11216 [Accessed 29 November 2012].
12. Snijders RJ, Thom EA, Zachary JM, Platt LD, Greene N, Jackson LG, Sabbagha RE, Filkins K, Silver RK, Hogge WA, Ginsberg NA, Beverly S, Morgan P, Blum K, Chilis P, Hill LM, Hecker J, Wapner RJ,. First-trimester trisomy screening: nuchal translucency measurement training and quality assurance to correct and unify technique. Ultrasound Obstet Gynecol 2002; 19: 353-359.
13. Herman A, Maymon R, Dreazen E, Caspi E, Bukovsky I, Weinraub Z,. Nuchal translucency audit: a novel image-scoring method. Ultrasound Obstet Gynecol 1998; 12: 398-403.
14. Palomaki GE, Neveux LM, Donnenfeld A, Lee JE, McDowell G, Canick JA, Summers A, Lambert-Messerlian G, Kellner LH, Zebelman A, Haddow JE,. Quality assessment of routine nuchal translucency measurements: a North American laboratory perspective. Genet Med 2008; 10: 131-138.
15. Sabrià J, Barcelõ-Vidal C, Arigita M, Jimenez JM, Puerto B, Borrell A,. The CUSUM test applied in prospective nuchal translucency quality review. Ultrasound Obstet Gynecol 2011; 37: 582-587.
16. Sahota DS, Leung WC, To WK, Chan WP, Lau TK, Leung TY,. Quality assurance of nuchal translucency for prenatal fetal Down syndrome screening. J Matern Fetal Neonatal Med 2012; 25: 1039-1043.
17. Benn PA, Kaminsky LM, Ying J, Borgida AF, Egan JF,. Combined second-trimester biochemical and ultrasound screening for Down syndrome. Obstet Gynecol 2002; 100: 1168-1176.
18. Borrell A, Mercade I, Casals E, Borobio V, Seres A, Soler A, Fortuny A, Cuckle H,. Combining fetal nuchal fold thickness with second trimester biochemistry to screen for trisomy 21. Ultrasound Obstet Gynecol 2007; 30: 941-945.
19. Maymon R, Levinsohn-Tavor O, Cuckle H, Tovbin Y, Dreazen E, Wiener Y, Herman A,. Second trimester ultrasound prenasal thickness combined with nasal bone length: a new method of Down syndrome screening. Prenat Diagn 2005; 25: 906-911.
20. Maymon R, Ushakov F, Waisman D, Cuckle H, Tovbin E, Herman A,. A model for second-trimester Down's syndrome sonographic screening based on facial landmarks and digit length measurement. Ultrasound Obstet Gynecol 2006; 27: 290-295.
21. Persico N, Borenstein M, Molina F, Azumendi G, Nicolaides KH,. Prenasal thickness in trisomy-21 fetuses at 16-24 weeks of gestation. Ultrasound Obstet Gynecol 2008; 32: 751-754.
22. Maymon R, Moskovitch M, Levinsohn-Tavor O, Weinraub Z, Herman A, Cuckle H,. Bed side estimation of Down's syndrome risk from second trimester ultrasound prenasal thickness. Ultrasound Obstet Gynecol 2009; 34: 629-633.
23. Miguelez J, Maymon R, Cuckle H, Zugaib M, Bunduki V, Herman A,. Model predicted performance of second trimester Down syndrome screening with ultrasound prenasal thickness. J Ultrasound Med 2010; 29: 1741-1747.
24. Miron J-P, Cuckle H, Miron P,. Prenasal thickness in first-trimester screening for Down syndrome. Prenat Diagn 2012; 32: 695-697.
25. De Jong-Pleij EA, Vos FI, Ribbert LS, Pistorius LR, Tromp E, Bilardo CM,. Prenasal thickness-to-nasal bone length ratio: a strong and simple second- and third-trimester marker for trisomy 21. Ultrasound Obstet Gynecol 2012; 39: 185-190.
26. Sonek J, Borenstein M, Downing C, McKenna D, Neiger R, Croom C, Genrich T, Nicolaides KH,. Fronto-maxillary facial angles in screening for trisomy 21 at 14-23 weeks' gestation. Am J Obstet Gynecol 2007; 197: 160. e1-5.
27. Molina F, Persico N, Borenstein M, Sonek J, Nicolaides KH,. Frontomaxillary facial angle in trisomy 21 fetuses at 16-24 weeks of gestation. Ultrasound Obstet Gynecol 2008; 31: 384-387.
28. Sonek J, Molina F, Hiett AK, Glover M, McKenna D, Nicolaides KH,. Prefrontal space ratio: comparison between trisomy 21 and euploid fetuses in the second trimester. Ultrasound Obstet Gynecol 2012; 40: 293-296.
29. Yazdi B, Sonek J, Oettling C, Hoopmann M, Abele H, Schaelike M, Kagan KO,. Prefrontal space ratio in second- and third-trimester screening for trisomy 21. Ultrasound Obstet Gynecol 2013; 41: 262-266.